watch
Vanda Pharmaceuticals, Inc.

Vanda Pharmaceuticals, Inc.

Sector: Pharmaceutical Preparations Region: DC, United States


: | Nasdaq: VNDA


Similar to: Guerbet SA, Ipsen SA, BioGaia AB

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. Its product portfolio includes Fanapt and Tasimelteon. The Fanapt product is a compound for the treatment of schizophrenia, the oral formulation of, which is currently being marketed and sold in the U.S. by Novartis. The Tasimelteon product is a compound for the treatment of sleep and mood disorders, including circadian rhythm sleep disorders, which is currently in clinical development. Vanda Pharmaceuticals was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

News & Analysis

You may also be interested in: